Pathfinder Cell Therapy, Inc. (PFND)
Develops cell therapies to repair organs damaged by diabetes, heart disease, and kidney failure.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
PFND is trading at the top of its 52-week range and above both its 50- and 200-day moving averages, showing an upward price structure. The stock carries a bullish sentiment score of 88/100. Analyst coverage appears unavailable for this micro-cap security.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$66,716
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—